198 related articles for article (PubMed ID: 18957616)
21. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients.
Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
J Heart Lung Transplant; 2005 Jun; 24(6):665-70. PubMed ID: 15949725
[TBL] [Abstract][Full Text] [Related]
22. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.
Mather KJ; Mirzamohammadi B; Lteif A; Steinberg HO; Baron AD
Diabetes; 2002 Dec; 51(12):3517-23. PubMed ID: 12453909
[TBL] [Abstract][Full Text] [Related]
23. Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity.
Schinzari F; Tesauro M; Veneziani A; Mores N; Di Daniele N; Cardillo C
Hypertension; 2018 Jan; 71(1):185-191. PubMed ID: 29203627
[TBL] [Abstract][Full Text] [Related]
24. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G; Baron AD
J Clin Invest; 1996 Jun; 97(11):2601-10. PubMed ID: 8647954
[TBL] [Abstract][Full Text] [Related]
25. A chronic physical activity treatment in obese rats normalizes the contributions of ET-1 and NO to insulin-mediated posterior cerebral artery vasodilation.
Olver TD; McDonald MW; Klakotskaia D; Richardson RA; Jasperse JL; Melling CWJ; Schachtman TR; Yang HT; Emter CA; Laughlin MH
J Appl Physiol (1985); 2017 Apr; 122(4):1040-1050. PubMed ID: 28183819
[TBL] [Abstract][Full Text] [Related]
26. Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats.
Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Huang HC; Lee SD
Eur J Clin Invest; 2004 Apr; 34(4):290-6. PubMed ID: 15086361
[TBL] [Abstract][Full Text] [Related]
27. Muscle contraction, but not insulin, increases microvascular blood volume in the presence of free fatty acid-induced insulin resistance.
Inyard AC; Chong DG; Klibanov AL; Barrett EJ
Diabetes; 2009 Nov; 58(11):2457-63. PubMed ID: 19675134
[TBL] [Abstract][Full Text] [Related]
28. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
[TBL] [Abstract][Full Text] [Related]
29. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
Ivy DD; Kinsella JP; Abman SH
J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146
[TBL] [Abstract][Full Text] [Related]
30. Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles.
Eringa EC; Stehouwer CD; Merlijn T; Westerhof N; Sipkema P
Cardiovasc Res; 2002 Dec; 56(3):464-71. PubMed ID: 12445887
[TBL] [Abstract][Full Text] [Related]
31. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.
Steinberg HO; Brechtel G; Johnson A; Fineberg N; Baron AD
J Clin Invest; 1994 Sep; 94(3):1172-9. PubMed ID: 8083357
[TBL] [Abstract][Full Text] [Related]
32. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
[TBL] [Abstract][Full Text] [Related]
33. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
[TBL] [Abstract][Full Text] [Related]
34. Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats.
Eringa EC; Stehouwer CD; Roos MH; Westerhof N; Sipkema P
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1134-9. PubMed ID: 17623751
[TBL] [Abstract][Full Text] [Related]
35. Vasoconstriction to endogenous endothelin-1 is impaired in patients with type II diabetes mellitus.
McAuley DF; Nugent AG; McGurk C; Maguire S; Hayes JR; Johnston GD
Clin Sci (Lond); 2000 Sep; 99(3):175-9. PubMed ID: 11787468
[TBL] [Abstract][Full Text] [Related]
36. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
[TBL] [Abstract][Full Text] [Related]
37. Role of endogenous ET-1 in the regulation of myocardial blood flow in lean and obese humans.
Mather KJ; Lteif AA; Veeneman E; Fain R; Giger S; Perry K; Hutchins GD
Obesity (Silver Spring); 2010 Jan; 18(1):63-70. PubMed ID: 19543207
[TBL] [Abstract][Full Text] [Related]
38. Insulin and endothelin in the acute regulation of adiponectin in vivo in humans.
Brame LA; Considine RV; Yamauchi M; Baron AD; Mather KJ
Obes Res; 2005 Mar; 13(3):582-8. PubMed ID: 15833944
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of endothelial function by endothelin antagonism in human saphenous vein conduits.
Dumont AS; Lovren F; McNeill JH; Sutherland GR; Triggle CR; Anderson TJ; Verma S
J Neurosurg; 2001 Feb; 94(2):281-6. PubMed ID: 11213966
[TBL] [Abstract][Full Text] [Related]
40. Role of endothelin-1 receptor antagonists in vasoconstriction mediated by endothelin and other vasoconstrictors in human internal mammary artery.
He GW; Liu MH; Yang Q; Furnary A; Yim AP
Ann Thorac Surg; 2007 Nov; 84(5):1522-7. PubMed ID: 17954056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
